Trifluoperazine Tablets are generically known as Trifluoperazine Hydrochloride Tablets and work by blocking dopamine receptors in the brain, acting as an antiemetic, sedative and anticholinergic. Trifluoperazine Hydrochloride Tablets is a kind of phenothiazine antipsychotics, which can exert the above effects by blocking the dopamine receptors in the medulla oblongata emetic chemoreceptor area, as well as directly inhibiting the vomiting center. It is used in the treatment of various types of schizophrenia, and can improve the symptoms of rigidity in the catatonic type, as well as the symptoms of behavioral withdrawal and emotional apathy in simple and chronic schizophrenia. It should be noted that trifluoperazine hydrochloride tablets are contraindicated in people who are allergic to any of the components of this drug, comatose, children under 6 years of age, and patients with glaucoma, basal ganglia lesions, Parkinson’s syndrome, myelosuppression, and Parkinson’s disease. Some patients may experience extrapyramidal reactions such as inability to sit still, acute dystonia, and adverse reactions such as palpitations (rapid heartbeat, often accompanied by panic), insomnia, dysuria, constipation, breast milk overflow, fatigue, dry mouth, blurred vision, menstrual disorders, amenorrhea, and other adverse reactions during the use of the drug, and if the discomfort symptoms are more serious, they should seek medical attention promptly. Patients should use Trifluoperazine Hydrochloride Tablets in accordance with medical advice and avoid self-medication, so as not to affect the condition.